Abdominal wall reconstruction using biosynthetic absorbable mesh in high-risk complex ventral hernia.

Area of Science:

• Abdominal wall reconstruction
• Surgical mesh technology
• Hernia repair outcomes

Background:

• Biosynthetic mesh may offer advantages over traditional meshes for complex ventral hernias.
• This study evaluates polyglycolic acid (PGA):trimethylene carbonate (TMC) mesh in high-risk patients.
• The mesh was used for midline fascial reinforcement in single-stage repairs.

Purpose of the Study:

• To evaluate the performance of PGA:TMC biosynthetic mesh.
• To assess outcomes in high-risk patients undergoing complex ventral hernia repair.
• To analyze recurrence rates, surgical site infections, and quality of life.

Main Methods:

• Retrospective review of 56 patients from May 2013 to August 2017.
• Open, single-stage complex ventral hernia repair using PGA:TMC mesh.
• Quality of life assessed using the Short Form-12 (SF-12) instrument.

Main Results:

• A low overall hernia recurrence rate of 3.6% was observed.
• Surgical site infection occurred in 26.8% of patients.
• Significant improvements in both physical and mental components of quality of life were reported.

Conclusions:

• Biosynthetic mesh demonstrates promising early outcomes in complex ventral hernia repair.
• Further well-controlled studies with longer follow-up are necessary.
• This study contributes data on a large series of abdominal wall reconstructions using biosynthetic mesh.